- Home
- MNOV vs JSPR Comparison
MNOV vs JSPR Comparison
Compare MNOV & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- JSPR
- Stock Information
- Founded
- MNOV 2000
- JSPR 2018
- Country
- MNOV United States
- JSPR United States
- Employees
- MNOV N/A
- JSPR N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNOV Health Care
- JSPR Health Care
- Exchange
- MNOV Nasdaq
- JSPR Nasdaq
- Market Cap
- MNOV 87.5M
- JSPR 85.8M
- IPO Year
- MNOV 2005
- JSPR N/A
- Fundamental
- Price
- MNOV $1.50
- JSPR $5.28
- Analyst Decision
- MNOV Strong Buy
- JSPR Strong Buy
- Analyst Count
- MNOV 1
- JSPR 11
- Target Price
- MNOV $9.00
- JSPR $62.50
- AVG Volume (30 Days)
- MNOV 19.6K
- JSPR 367.2K
- Earning Date
- MNOV 02-19-2025
- JSPR 02-27-2025
- Dividend Yield
- MNOV N/A
- JSPR N/A
- EPS Growth
- MNOV N/A
- JSPR N/A
- EPS
- MNOV N/A
- JSPR N/A
- Revenue
- MNOV N/A
- JSPR N/A
- Revenue This Year
- MNOV N/A
- JSPR N/A
- Revenue Next Year
- MNOV N/A
- JSPR N/A
- P/E Ratio
- MNOV N/A
- JSPR N/A
- Revenue Growth
- MNOV N/A
- JSPR N/A
- 52 Week Low
- MNOV $1.12
- JSPR $4.55
- 52 Week High
- MNOV $2.55
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- MNOV 29.71
- JSPR 35.52
- Support Level
- MNOV $1.45
- JSPR $5.02
- Resistance Level
- MNOV $1.51
- JSPR $5.84
- Average True Range (ATR)
- MNOV 0.07
- JSPR 0.45
- MACD
- MNOV -0.02
- JSPR 0.19
- Stochastic Oscillator
- MNOV 7.50
- JSPR 27.05
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.